Prof. Angelo D'Alessandro

Angelo D’Alessandro is a tenured Professor at the Department of Biochemistry and Molecular Genetics at the University of Colorado Denver—Anschutz Medical Campus. He is also the founder and director of the Metabolomics Core of the School of Medicine and Colorado Cancer Center. He received his Ph.D. at the Tuscia University (Italy) under the aegis of the Italian National Blood Center. His postdoctoral career focused on Mass Spectrometry-based Omics technologies at Bruker Daltonics (Bremen, Germany), the Beatson Institute for Cancer Center (Glasgow, Scotland), and the University of Colorado Denver (Aurora, USA). He also serves as a Linda Crnic Investigator for the Linda Crnic Institute of Down Syndrome. He is a founder and CSO of Omix Technologies Inc. and Altis Biosciences LLC. He serves as Associate Editor for the journal Blood Transfusion. He has been awarded the 2015 Scott Murphy lectureship by the Biomedical Excellence for Safer Transfusion (BEST) group, the Early Career grant by the National Blood Foundation (2016), the 2017 Webb-Waring Early Career grant by the Boettcher Foundation, NBF Scholar (2018), Jean Julliard Award by ISBT (2020), and NBF Innovation Award (2020), and he was inducted into the AABB Hall of Fame (2023).